Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shao-Jui Lai"'
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 59:134-143
Objectives Cholesterol efflux capacity (CEC), an atheroprotective function of high-density lipoprotein, is expected to be a potential biomarker for cardiovascular disease. However, CEC has not been widely introduced for application in clinical labora
Publikováno v:
Bioscience Reports
Cholesterol efflux capacity (CEC) is an atheroprotective function of high-density lipoprotein (HDL). CEC is currently measured using artificially prepared foam cells composed of cultured macrophage and 3H-cholesterol. However, this conventional metho
Autor:
Shitsuko Shimano, Takahiro Kameda, Yuna Horiuchi, Shao-Jui Lai, Ryunosuke Ohkawa, Michio Hagihara, Minoru Tozuka, Shuji Tohda
Publikováno v:
Bioscience Reports
Cholesterol efflux capacity (CEC) in atherosclerotic lesions is the main anti-atherosclerotic function of high-density lipoprotein (HDL). In recent studies, apolipoprotein (apo) B-depleted serum (BDS) obtained with the polyethylene glycol (PEG) preci
Autor:
Michio Hagihara, Ryunosuke Ohkawa, Takahiro Kameda, Shuji Tohda, Shitsuko Shimano, Azusa Yamazaki, Kouji Yano, Yuna Horiuchi, Ayaka Nakamura, Shigeo Okubo, Shao-Jui Lai, Minoru Tozuka
Publikováno v:
Bioscience Reports
Estimation of the function as well as the amount of high-density lipoprotein (HDL) is required to predict the risk of cardiovascular disease development. Cholesterol efflux capacity (CEC) is the key metric for determining the antiatherosclerotic func
Autor:
Yuna Horiuchi, Ryunosuke Ohkawa, Minoru Tozuka, Shao-Jui Lai, Shitsuko Shimano, Michio Hagihara, Shuji Tohda, Takahiro Kameda
Publikováno v:
Bioscience Reports; 4/30/2019, Vol. 39 Issue 4, p1-10, 10p